Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models

被引:167
作者
Fujimoto, M
Takaki, E
Hayashi, T
Kitaura, Y
Tanaka, Y
Inouye, S
Nakai, A [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7758505, Japan
[2] Osaka Med Coll, Dept Med 3, Osaka 5698686, Japan
关键词
D O I
10.1074/jbc.M506288200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyglutamine diseases are inherited neurodegenerative diseases characterized by misfolding and aggregation of proteins possessing expanded polyglutamine repeats. As overexpression of some heat shock protein (Hsp) suppresses polyglutamine aggregates and cell death, it is assumed that combined overexpression of Hsps will suppress that more effectively. Here, we examined the impact of active forms of heat shock transcription factor 1 (HSF1), which induces a set of Hsps, on polyglutamine inclusion formation and disease progression. We found that active HSF1 suppressed polyglutamine inclusion formation more significantly than any combination of Hsps in culture cells, possibly by regulating expression of unknown genes, as well as major Hsps. We crossed R6/2 Huntington disease mice with transgenic mice expressing an active HSF1 (HSF1Tg). Analysis of the skeletal muscle revealed that the polyglutamine inclusion formation and its weight loss were improved in R6/2/HSF1Tg mice. Unexpectedly, the life span of R6/2/HSF1Tg mice was significantly improved, although active HSF1 is not expressed in the brain. These results indicated that active HSF1 has a strong inhibitory effect on polyglutamine aggregate formation in vivo and in vitro.
引用
收藏
页码:34908 / 34916
页数:9
相关论文
共 59 条
[1]  
Adachi H, 2003, J NEUROSCI, V23, P2203
[2]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[3]   MUSCLE FIBER TYPES - HOW MANY AND WHAT KIND [J].
BROOKE, MH ;
KAISER, KK .
ARCHIVES OF NEUROLOGY, 1970, 23 (04) :369-&
[4]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[5]   The Hsp70 and Hsp60 chaperone machines [J].
Bukau, B ;
Horwich, AL .
CELL, 1998, 92 (03) :351-366
[6]   Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease [J].
Carmichael, J ;
Chatellier, J ;
Woolfson, A ;
Milstein, C ;
Fersht, AR ;
Rubinsztein, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9701-9705
[7]  
Chai YH, 1999, J NEUROSCI, V19, P10338
[8]   Mechanisms of chaperone suppression of polyglutamine disease:: selectivity, synergy and medullation of protein solubility in Drosophila [J].
Chan, HYE ;
Warrick, JM ;
Gray-Board, GL ;
Paulson, HL ;
Bonini, NM .
HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2811-2820
[9]   Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice [J].
Cummings, CJ ;
Sun, YL ;
Opal, P ;
Antalffy, B ;
Mestril, R ;
Orr, HT ;
Dillmann, WH ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2001, 10 (14) :1511-1518
[10]   Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 [J].
Cummings, CJ ;
Mancini, MA ;
Antalffy, B ;
DeFranco, DB ;
Orr, HT ;
Zoghbi, HY .
NATURE GENETICS, 1998, 19 (02) :148-154